site stats

Suzhou kintor pharmaceuticals

Splet14. jan. 2024 · 30 Apr 2024 Discontinued - Phase-II for Cancer in China (IV) (Suzhou Kintor Pharmaceuticals pipeline, April 2024) 30 Apr 2024 Discontinued - Phase-II for Liver … SpletKintor Pharmaceutical Limited PREV NEXT 关于我们 我们致力于全球高发病率癌症及其它未满足临床需求的疾病领域,尤其是AR相关疾病和肿瘤领域 深耕新冠、前列腺癌、脱发、痤疮、肝癌和乳腺癌等缺乏有效治疗手段、 …

China Orient Asset Management (International) Holding

Splet27. okt. 2024 · Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the … Splet09. apr. 2024 · Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological … scythe peening hand anvil https://cyborgenisys.com

Research programme: ALK1 and VEGF bispecific antibody

Splet23. mar. 2024 · At a glance. Originator Suzhou Kintor Pharmaceuticals. Class Antiacnes; Aza compounds; Benzamides; Fluorobenzenes; Foot disorder therapies; Imidazolidines; … Splet20. jul. 2024 · A Agência Nacional de Vigilância Sanitária (Anvisa) autorizou, nesta segunda-feira (19), a realização de estudo clínico para avaliar a segurança, a eficácia e a imunogenicidade da aplicação de terceira dose da vacina contra covid-19 da AstraZeneca. Splet18. jun. 2024 · Suzhou Kintor Pharmaceuticals, Inc Professor Yifeng Zhou Medical College of Soochow University Qiang Guo First Affiliagted Hospital of Soochow University Date Written: April 20, 2024 Abstract Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a worldwide pandemic named coronavirus disease … scythe pendant

Kintor Pharmaceutical (SEHK:9939) - Stock Price, News & Analysis …

Category:Author Page for Youzhi Tong :: SSRN

Tags:Suzhou kintor pharmaceuticals

Suzhou kintor pharmaceuticals

Suzhou Kintor Pharmaceuticals, Inc

Splet14. apr. 2024 · Kintor Pharmaceuticals is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor-related … Splet18. jun. 2024 · Suzhou Kintor Pharmaceuticals, Inc. Rui Wu. Soochow University - Medical College. Shenghua Zhang. Soochow University - Medical College. Jiangnan Zheng. …

Suzhou kintor pharmaceuticals

Did you know?

SpletMedicamento oral em testes para o tratamento de câncer de próstata e de mama, em estudos de fase III para mCRPC (Câncer de próstata) como monoterapia e em combinação com abiraterona, desenvolvido pela indústria farmacêutica chinesa Suzhou Kintor Pharmaceuticals, uma subsidiária da Kintor Pharmaceutical Limited, e atualmente está … SpletPyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – …

SpletSoochow University - Medical College, Soochow University, Department of Pharmacy, Suzhou Kintor Pharmaceuticals, Inc, Soochow University, Shanghai Jiao Tong University (SJTU) - Department of Critical Care Medicine, Government of the People's Republic of China - Department of Pulmonary and Critical Care Medicine, Soochow University - … SpletDetorsertib (also known as a GT 0486) is a small molecule, mTOR kinase inhibitor is being developed by Suzhou Kintor Pharmaceuticals, for the treatment of Detorsertib - Suzhou …

SpletFounder of Kintor Pharmaceutical Ltd. and Suzhou Kintor Pharmaceuticals, Inc., You Zhi Tong currently occupies the position of Chairman & Chief Executive Officer of Kintor Pharmaceutical Ltd. and Chairman & Chief Executive Officer of Suzhou Kintor Pharmaceuticals, Inc. (a subsidiary of Kintor Pharmaceutical Ltd.). Splet06. feb. 2024 · 06 Feb 2024 Suzhou Kintor Pharmaceuticals intends to submit NDA for Prostate cancer (Monotherapy, Metastatic disease, Hormone refractory) in China, in early …

Splet31. jan. 2024 · In October 2024, Asieris Pharmaceuticals initiated a Multi-center, Randomized, Open-label, ... Pfizer, Clovis Oncology, Regeneron Pharmaceuticals, Suzhou Kintor Pharmaceutical, ...

SpletAbout. SUZHOU KINTOR PHARMACEUTICALS INC has a total of 29 patent applications. It decreased the IP activity by 78.0%. Its first patent ever was published in 2010. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals ... pdt to poland timeSplet18. jun. 2024 · Number of pages: 29 Posted: 14 Apr 2024. Ruoyun Wanga, Tong Zhou, Liu Jie, Xinwen Zhang, Jianfei Yang, Wenbin Hu and Liu Lei. affiliation not provided to SSRN, affiliation not provided to SSRN, Northeast Forestry University, Chinese Academy of Sciences (CAS) - State Key Laboratory of Drug Research, Suzhou Kintor Pharmaceuticals, … pdt to sydney time converterSpletLegal Name Suzhou Kintor Pharmaceuticals, Inc. Company Type For Profit Contact Email [email protected] Phone Number +86-512-62956307 Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast … pdt to php timeSpletAddress: 20 Songbei Rd. Suzhou Industrial Park, China (Jiangsu) Pilot Free Trade Zone Suzhou, Jiangsu, 215000 China See other locations Phone: ? Website: www.kintor.com.cn scythe philibertSplet06. mar. 2024 · Suzhou Kintor Pharmaceuticals, Inc. (“Kintor”) signed Technology Transfer Agreement with Peking University (“PKU”) at Yingjie Exchange Center of Peking University. Leaders from relevant departments and Faculty of Chemistry of PKU participated in the signing ceremony. pdt to swedish timeSplet08. sep. 2024 · Alternative Names: ALK-1/VEGF bispecific antibody - Suzhou Kintor Pharmaceuticals Latest Information Update: 08 Sep 2024. Price : $50 * Buy Profile. Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. ... pdt to new york timeSplet01. jan. 2009 · Suzhou Kintor Pharmaceuticals, Inc. ("Suzhou Kintor" or the "Group") has been formally registered in Suzhou. Previous: The Group's first project, GT0918 … scythe phantom forces